Article

Adverse Events Among the Elderly Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer

Department of Epidemiology, University of Iowa, Iowa City, IA 52242, USA. .
Journal of Clinical Oncology (Impact Factor: 17.88). 02/2010; 28(4):620-7. DOI: 10.1200/JCO.2009.23.8485
Source: PubMed

ABSTRACT To describe chemotherapy use and adverse events (AEs) for advanced-stage, non-small-cell lung cancer (NSCLC) in community practice, including descriptions according to variation by age.
We interviewed patients with newly diagnosed, stages IIIB and IV NSCLC in the population-based cohort studied by the Cancer Care Outcomes Research and Surveillance Consortium, and we abstracted the patient medical records. AEs were medical events occurring during chemotherapy. Using logistic regression, we assessed the association between age and chemotherapy; with Poisson regression, we estimated event rate ratios and adjusted the analysis for age, sex, ethnicity, radiation therapy, stage, histology, and presence and grade of 27 comorbidities.
Of 1,371 patients, 58% (95% CI, 55% to 61%) received chemotherapy and 35% (95% CI, 32% to 38%) had AEs. After adjustment, 72% (95% CI, 65% to 79%) of those younger than 55 years and 47% (95% CI, 42% to 52%) of those age 75 years and older received chemotherapy. Platinum-based therapies were less common in the older-age groups. Pretreatment medical event rates were 18.6% for patients younger than 55 years and were only 9.2% for those age 75 years and older (adjusted rate ratio, 0.49; 95% CI, 0.26 to 0.91). In contrast, older adults were more likely to have AEs during chemotherapy. The adjusted rate ratios compared with age younger than 55 years were 1.70 for 65- to 74-year-olds (95% CI, 1.19 to 2.43) and 1.34 for those age 75 years and older (95% CI, 0.90 to 2.00).
Older patients who received chemotherapy had fewer pretherapy events than younger patients and were less likely to receive platinum-based regimens. Nevertheless, older patients had more adverse events during chemotherapy, independent of comorbidity. Potential implicit trade-offs between symptom management and treatment toxicity should be made explicit and additionally studied.

Download full-text

Full-text

Available from: Yousuf Zafar, Jul 06, 2015
1 Follower
 · 
148 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: At present, there is a shortage of detailed data on head and neck cancer treatment in acute care hospitals in Japan. We conducted an analysis of the care process for laryngeal cancer inpatients in Japan using a national administrative database based on the case-mix system known as the Diagnosis Procedure Combination to evaluate the recent clinical situation of a relatively high incidence of head and neck cancers. We obtained discharge data relating to 2790 cases (one case = one hospitalization) involving 2319 laryngeal cancer patients from 346 acute care hospitals that participated in the Japanese national case-mix project between July and December of 2008. The details of their treatment procedures were analyzed according to the Japanese procedure codes managed by the Ministry of Health, Labour, and Welfare of Japan. There were 2156 male and 163 female patients. The median age was 69 years (range: 22-96 years). The most frequent surgical procedure was endoscopic resection which was performed for 781 cases. Chemotherapy was given in 31.6% of cases in the < 60 age group, 28.2% in the 60-79, and 14.1% in the ≥ 80. The most frequently used chemotherapy regimen was a single drug, S-1 (compound of tegafur, gimeracil and oteracil potassium), which was more frequently used in the ≥ 70 age group than in the younger age group. The Diagnosis Procedure Combination database, which collects a large volume of data from all over the country, is useful for analysis of the care process for head and neck cancers in Japan.
    The Tohoku Journal of Experimental Medicine 01/2011; 223(1):61-6. DOI:10.1620/tjem.223.61 · 1.28 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A mission management system comprises the processes that perform tactical decision making tasks for an unmanned vehicle system. As such, it is the primary determinant of the range of realizable behaviors, versatility and ultimately the operational effectiveness of any class of Unmanned Air Vehicles (UAVs). The Mission Management System (MMS) project is an on-going program to develop a unified system architecture to provide ground-based and in-flight mission management for a reconfigurable class of cooperating UAVs. This distributed architecture enables integrated automated and manual planning to be applied to a hierarchy of operational levels, from the entire theater to individual vehicles. This paper presents an overview of the MMS motivations, requirements, and architectural design. A local MMS node, present at every cooperating site, manager the local platform resources and provides reaction capabilities m well as intelligent planning for “optimal” responses. Each node is an independent agent in the cooperation and negotiation process, using an interaction model analogous to a team of cooperating humane. The MMS design approach combines object-oriented analysis and design with rapid application development. Each node is layered defining “virtual machines” which provide standardized interfaces to promote reuse, flexibility, sad simplified development and maintenance. The architecture has been used to demonstrate both a ground-based planning prototype for unmanned missiles and a simulation of several cooperating UAVs
    Aerospace and Electronics Conference, 1994. NAECON 1994., Proceedings of the IEEE 1994 National; 06/1994
  • [Show abstract] [Hide abstract]
    ABSTRACT: A method is presented for theoretically investigating the properties of a one-atom micromaser with stationary non-Poissonian pumping. The method is based on treating the statistics of the arrival times of the individual pump atoms with the help of the theory of stochastic point processes. Considerable simplification is achieved by assuming the pump statistics to be described by a stationary renewal process. Thus the influence of super- as well as sub-Poissonian pumping with different strengths of correlation between the pump atoms and different correlation decay times may be studied quantitatively. The level-selective statistics of the atoms leaving the cavity is investigated as well as the photon statistics of the cavity field. Moreover, the relation to the other models used in the literature for describing the micromaser pump statistics is discussed. It is found that for sub- (super-)Poissonian pumping, the stationary expectation value of the cavity photon number (which corresponds to its time-averaged value) is larger (smaller) than the conditioned mean photon number that would result from averaging over the number of photons present in the cavity at the time instants immediately before the injection of the individual pump atoms. For Poissonian pumping, both quantities are shown to be equal. The relative standard deviation of the stationary cavity photon number is decreased (increased) for sub- (super-) Poissonian pumping, in comparison to the corresponding values that would result from Poissonian pumping. Moreover, it turns out that for sub- (super-)Poissonian pumping, the normalized coincidence probability density for the detection of the outgoing deexcited atoms is smaller (larger) than the normalized cavity field intensity correlation function at zero time delay. The difference decreases with increasing lifetime of the pump-atom correlations. (Abstract Truncated)
    Physical Review A 08/1995; 52(1):602-618. DOI:10.1103/PhysRevA.52.602 · 2.99 Impact Factor